Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
The Conversation logo

Cognitive behavioural therapy (CBT) is one of the most common treatments for many different mental health conditions. This talking therapy aims to help people by identifying unhelpful thoughts and patterns of behaviour and promoting new ways of thinking. It’s used to treat a variety of common conditions, such as anxiety and depression – and is even used to help manage physical health conditions, such as chronic pain, cancer and diabetes.

CBT is also the most researched psychological therapy in the world. Once it was shown to be helpful for one condition, researchers began testing it across many others. But though plenty of time, money, and resources have been put into investigating the effectiveness of CBT, our recent study has shown that only a small proportion of the research is known to have included data from non-white ethnic groups. This means we may not fully know if CBT actually does work equally well for people from different ethnic groups, religions and cultural groups.

Read the full article on The Conversation website, written by Beth Fordham (Nuffield Department of Orthopaedics, Rheumatology & Musculoskeletal Sciences)

Oxford is a subscribing member of The ConversationFind out how you can write for The Conversation.

Similar stories

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.

Three NHSBT research units launch at University of Oxford

The NIHR has awarded three new Blood and Transplant Research Units (BTRUs) to the University of Oxford.

Fourth COVID-19 vaccine dose provides stronger immunity boost than third dose, shows UK study

COVID-19 vaccines given as fourth doses in the UK offer excellent boosting immunity protection, according to the latest results from a nationwide NIHR-supported study.

COVID-19’s high blood clot risk

A recent study of patient health records found that around 1 in 100 people with COVID-19 had a venal or arterial thrombosis, with rates higher still among males, and particularly for those hospitalised.

Medical Sciences Division receives REF 2021 results

Today the UK Funding Bodies have published the outcomes of the recent national research assessment exercise, the Research Excellence Framework (REF) 2021. REF is the UK-wide assessment of research in universities, and provides an expert evaluation of the quality of the research outputs, impact and environment at subject level in each university.